Tai Jingyu, Guo Aimin, Chen Juntong, Li Haoyu, Dong Qian, Hao Wumei, Wang Wenjing, Li Zunzhu, Ye Jianshu, Liu Jinbang, Yang Chengwu
School of Nursing, Peking Union Medical College, Beijing, China.
Intensive Care Medicine Department of Peking Union Medical College Hospital, Beijing, China.
Front Oncol. 2025 Jul 30;15:1644178. doi: 10.3389/fonc.2025.1644178. eCollection 2025.
To comprehensively evaluate the efficacy and safety of non-pharmacological interventions for radiotherapy-induced xerostomia in patients with head and neck cancer.
A systematic literature search was conducted in PubMed, Embase, the Cochrane Library, and Web of Science for articles published up to March 1, 2025. Three outcome measures were utilized to assess treatment effectiveness: xerostomia, saliva flow rate, and xerostomia-related quality of life. A Bayesian network meta-analysis was employed to synthesize the comparative performance of different non-pharmacological interventions. The study protocol was registered in the PROSPERO database (CRD420251027019).
A total of 30 RCTs encompassing 1,595 participants and nine distinct non-pharmacological treatment modalities were included. Compared with the SOC, mouthwash demonstrated the most pronounced improvement in XQ (SMD = -0.70; 95% CI: -1.38 to -0.01) and XI scores (SMD = -0.68; 95% CI: -1.09 to -0.26). Oral moisturizing gel exhibited the greatest reduction in VAS scores (SMD = -1.55; 95% CI: -2.31 to -0.80). Regarding salivary flow enhancement, oral moisturizing gel was most effective in increasing USFR (SMD = 3.83; 95% CI: 0.56 to 7.09), while chewing gum provided the highest gain in SSFR (SMD=3.66; 95%CI: -0.08 to 7.41). Among safety outcomes, electrical stimulation therapy was associated with the most favorable profile relative to SOC (SMD = -1.82; 95% CI: -3.96 to 0.33).
Non-pharmacological interventions appear to offer superior efficacy with comparable safety to SOC in care of radiotherapy-induced xerostomia among patients with head and neck cancer. Mouthwash is likely the most effective option for alleviating subjective xerostomia symptoms, with oral moisturizing gel as a valuable alternative. For salivary flow enhancement, oral moisturizing gel is preferred for unstimulated flow, whereas chewing gum is optimal for stimulated flow. Electrical stimulation therapy may yield the most substantial improvement in quality of life, with photobiomodulation therapy representing a promising adjunctive strategy.
Prospective Register of Systematic Reviews (PROSPERO), identifier CRD420251027019.
全面评估非药物干预对头颈部癌患者放疗所致口干症的疗效和安全性。
在PubMed、Embase、Cochrane图书馆和Web of Science中进行系统文献检索,以查找截至2025年3月1日发表的文章。采用三项结局指标评估治疗效果:口干症、唾液流速和与口干症相关的生活质量。采用贝叶斯网络荟萃分析来综合不同非药物干预的比较性能。该研究方案已在PROSPERO数据库(CRD420251027019)中注册。
共纳入30项随机对照试验,涉及1595名参与者和9种不同的非药物治疗方式。与标准治疗相比,漱口水在口干症问卷(XQ)得分(标准化均值差[SMD]=-0.70;95%置信区间[CI]:-1.38至-0.01)和口干指数(XI)得分(SMD=-0.68;95%CI:-1.09至-0.26)方面显示出最显著的改善。口腔保湿凝胶在视觉模拟量表(VAS)得分方面降低幅度最大(SMD=-1.55;95%CI:-2.31至-0.80)。在促进唾液分泌方面,口腔保湿凝胶在增加非刺激性唾液流速(USFR)方面最有效(SMD=3.83;95%CI:0.56至7.09),而口香糖在刺激性唾液流速(SSFR)增加方面效果最佳(SMD=3.66;95%CI:-0.08至7.41)。在安全性结局方面,与标准治疗相比,电刺激疗法的安全性概况最为有利(SMD=-1.82;95%CI:-3.96至0.33)。
在对头颈部癌患者放疗所致口干症的护理中,非药物干预似乎具有优于标准治疗的疗效且安全性相当。漱口水可能是缓解主观口干症状最有效的选择,口腔保湿凝胶是一种有价值的替代方案。在促进唾液分泌方面,口腔保湿凝胶对非刺激性唾液分泌更有效,而口香糖对刺激性唾液分泌效果最佳。电刺激疗法可能在生活质量方面带来最显著的改善,光生物调节疗法是一种有前景的辅助策略。
系统评价前瞻性注册库(PROSPERO),标识符CRD420251027019。